Radioiodine in the management of benign thyroid disease: clincial guidelines

£0.00 £0.00

Hyperthyroidism affects more than one in 200 people. While the original guidelines were influential in standardising treatment of the condition within the UK, these guidelines (published in 2007) set out the latest recommendations for its management. Their scope has been widened to include the use of radioiodine to treat sporadic goitre; this treatment is now becoming established as a useful alternative to surgery for this condition.

The guidelines, which are available to download as a pdf, also cover changes in legislation relating to radioiodine administration and the effect of radioiodine on thyroid eye disease.

As well as specialists directly involved in the management of patients with hyperthyroidsim or goitre, the guidelines will be of interest to general physicians and general practitioners who are frequently involved with the follow-up for patients with this prevalent condition.


  • Overview of radioiodine therapy
  • Administration of radioiodine
  • Management of the first year following radioiodine therapy for thyrotoxicosis
  • Monitoring and follow-up after the first year
  • Appendices
  • Special precautions
  • Information for patients
  • Sample consent form
  • Sample patient information card
  • Elements of a system to support long-term follow-up of patients treated with radioiodine